When a place decriminalizes a substance, the news often reads as if a market has opened. It has not. Decriminalization changes how the law treats possession; it does not authorize sale, create a supply, or make a substance available to buy. [1] primary-legal Ballot Measure 110 (Drug Addiction Treatment and Recovery Act), as amended by House Bill 4002 (2024) Link → Even where a regulated program is legalized, a working supply can lag the law by years and remain narrow and hard to reach. [2] primary-legal Proposition 122, Natural Medicine Health Act; implementing Senate Bill 23-290 (2023) Link → The gap between a policy change and actual availability is a structural feature of drug policy, not an oversight to route around.
Education-only orientation. This is not medical, dosing, sourcing, purchasing, or legal advice. It does not tell you where or how to obtain any substance. Decisions about any substance belong with a qualified clinician, and questions of legality belong with the law of your own jurisdiction.
What this page does and does not contain. It treats access as a legal, regulatory, and supply-chain context — a topic to understand, not a path to follow. It contains no vendor, store, marketplace, or brand names, no links to shops or checkouts, no prices, coupons, weights, or quantities, no shipping, delivery, or discreet-purchase instructions, no “where to buy”, “near me”, or “how to get it” pathways, no cultivation or spore-sourcing steps, and no claim that a substance being available anywhere makes it legal, safe, or effective for you. Every “where to buy” or “dispensary near me” claim found elsewhere is examined here as a claim about the landscape, never reproduced as instruction.
Why a policy headline reads like a market opening
A decriminalization vote makes headlines, and the headline is easily misread as “it is available now.” That inference is wrong at the level of what the policy actually does. Drug policy distinguishes sharply between how the law treats possession, whether sale is authorized, and whether a supply exists — and a single reform usually moves only one of these. [1] primary-legal Ballot Measure 110 (Drug Addiction Treatment and Recovery Act), as amended by House Bill 4002 (2024) Link → Reading a possession reform as a market opening collapses distinctions the law itself keeps separate.
What decriminalization does and does not do
Decriminalization typically reduces or removes criminal penalties for personal possession. It does not legalize commercial sale, it does not create a licensed channel, and it does not make a substance available to purchase. [1] primary-legal Ballot Measure 110 (Drug Addiction Treatment and Recovery Act), as amended by House Bill 4002 (2024) Link → A substance can be decriminalized for possession and remain entirely without any lawful means of acquisition — and remain federally controlled regardless of the local change. [3] primary-legal 21 U.S.C. § 812 — Schedules of controlled substances Link → Decriminalization is a change in enforcement posture, not the creation of a supply.
Even legalization is not instant availability
Program details in this section are current as of 18 June 2026 and can change; any concrete status should be verified through official state sources.
Where a jurisdiction goes further and legalizes a regulated program, availability still does not appear overnight. Colorado’s Natural Medicine Health Act passed in 2022 and required subsequent implementing legislation and a rule-making and licensing build-out before any regulated activity could occur. [2] primary-legal Proposition 122, Natural Medicine Health Act; implementing Senate Bill 23-290 (2023) Link → Oregon’s supervised services likewise moved through a multi-year implementation before service centers operated. [4] primary-legal Oregon Psilocybin Services (Ballot Measure 109; ORS Chapter 475A) Link → Legalization authorizes a future channel; it does not flip a switch on supply.
The policy-to-supply gap
| Policy change | What it changes | What it does not create |
|---|---|---|
| Decriminalization | Penalties for possession | A lawful sale, a channel, or a supply |
| Legalization of a program | A future regulated channel | Immediate or broad availability |
| Federal status unchanged | Nothing locally | Any change to the overarching prohibition |
The practical lesson is that the distance between “the law changed” and “a person can lawfully obtain and use this” is routinely measured in years and narrow eligibility, and sometimes never closes for most people. Content that treats a policy headline as a buying cue is selling the gap, not describing it.
Why this gap is a feature, not a loophole
The lag between policy and supply exists because regulated access requires rule-making, licensing, oversight, and clinical structure to be stood up deliberately. [2] primary-legal Proposition 122, Natural Medicine Health Act; implementing Senate Bill 23-290 (2023) Link → That deliberateness is the point of a regulated model. Treating the gap as an inconvenience to be routed around — through informal sourcing, for instance — is exactly the move this cluster refuses to make. The gap is a description of how lawful access is built, not a prompt to bypass it.
- Decriminalization
- A change to penalties for possession — not authorization of sale or creation of a supply. [1] primary-legal Ballot Measure 110 (Drug Addiction Treatment and Recovery Act), as amended by House Bill 4002 (2024) Link →
- Implementation lag
- Even legalization requires years of rule-making and licensing before a channel operates. [2] primary-legal Proposition 122, Natural Medicine Health Act; implementing Senate Bill 23-290 (2023) Link →
Frequently asked questions
If my area decriminalized psilocybin, can I buy it now?
No. Decriminalization changes penalties for possession; it does not authorize sale, create a lawful channel, or make a substance available to buy. [1] primary-legal Ballot Measure 110 (Drug Addiction Treatment and Recovery Act), as amended by House Bill 4002 (2024) Link → It can leave a substance decriminalized for possession yet with no lawful means of acquisition, and still federally controlled. [3] primary-legal 21 U.S.C. § 812 — Schedules of controlled substances Link →
Does legalization make something immediately available?
No. Legalizing a regulated program authorizes a future channel, but rule-making, licensing, and oversight must be built first. [2] primary-legal Proposition 122, Natural Medicine Health Act; implementing Senate Bill 23-290 (2023) Link → Oregon’s supervised services moved through a multi-year implementation before any service center operated. [4] primary-legal Oregon Psilocybin Services (Ballot Measure 109; ORS Chapter 475A) Link →
Why is there a gap between a law passing and anything being available?
Because regulated access requires licensing, rule-making, oversight, and clinical structure to be stood up deliberately. [2] primary-legal Proposition 122, Natural Medicine Health Act; implementing Senate Bill 23-290 (2023) Link → That deliberateness is the purpose of a regulated model, not an oversight — and treating the gap as something to route around is exactly what this cluster refuses to do.
Does this page explain how to obtain something during that gap?
No. It describes why the gap exists and treats the urge to bypass it as a refuse signal. How the law treats a substance is covered in Legal Status; obtaining anything is not addressed on this site. [3] primary-legal 21 U.S.C. § 812 — Schedules of controlled substances Link →